Healio

Schirmer’s test reliably predicts dry eye outcomes

Please provide your email address to receive an email when new articles are posted on . Lower Schirmer’s test score correlated with increased corneal staining and more severe disease burden among ...
Healio

VIDEO: Schirmer’s test comparable to other tools when capturing dry eye intensity

Please provide your email address to receive an email when new articles are posted on . In this Healio Video Perspective from the virtual ARVO meeting, Jeffrey Gemi, MD, discusses the usability of ...
Business Wire

Aldeyra Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Reproxalap in Dry Eye Disease

LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced the designation of Schirmer test, a measure of tear production, as the sole primary endpoint in ...
FierceBiotech

After late-study endpoint switch, Aldeyra hails success of phase 3 dry eye disease trial

Aldeyra Therapeutics’ late-study primary endpoint switch has paid off. Weeks after disclosing the change to its dry eye disease phase 3 trial, the biotech has reported a hit against the new primary ...
Business Wire

Aldeyra Therapeutics to Host Conference Call and Webcast to Discuss Top-Line Symptom, Redness, and Schirmer’s Test Results from Run-in Cohort of Phase 3 TRANQUILITY Trial

LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call and webcast at 8:00 a.m. ET Thursday, January 7, 2021, to discuss top-line symptom, ...